| Outcome Measures: |
Primary: Change from Baseline in alanine amino transferase level to Day 35, 35 days|Change from baseline in Creatinine level to Day 35, 35 days|Change from baseline in the count of Red blood cells to Day 35, 35 days|Change from baseline in White blood cells count to Day 35, 35 days|Change from baseline in Creatinine kinase level to Day 35, 35 days | Secondary: Change from baseline in Fasting plasma glucose level to Day 28, 28 days|Change from baseline in Adiponectin level to Day 28, 28 days|Change from baseline in Triglycerides level to Day 28, 28 days|Change from baseline in High density lipoprotein cholesterol level to Day 28, 28 days
|
| Locations: |
Site Reference ID/Investigator# 54183, Dimitrovgrad, 6400, Bulgaria|Site Reference ID/Investigator# 54182, Pleven, 5800, Bulgaria|Site Reference ID/Investigator# 44722, Plovdiv, 4000, Bulgaria|Site Reference ID/Investigator# 44723, Sofia, 1407, Bulgaria|Site Reference ID/Investigator# 44725, Lubin, 59-301, Poland|Site Reference ID/Investigator# 44724, Pulawy, 24-100, Poland|Site Reference ID/Investigator# 54185, Radzymin, 05-250, Poland|Site Reference ID/Investigator# 44727, Ruda Slaska, Poland|Site Reference ID/Investigator# 54184, Wroclaw, 50-349, Poland|Site Reference ID/Investigator# 44728, Cape Town, 7130, South Africa|Site Reference ID/Investigator# 44730, Cape Town, 7937, South Africa|Site Reference ID/Investigator# 44729, Johannesburg, 2198, South Africa
|
